{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:50:50Z","timestamp":1794293450167,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuromyelitis optica spectrum disorder (NMOSD) is associated with inflammatory mediators that may also trigger downstream signaling pathways leading to reduce insulin sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We aimed to determine the risk association of hyperinsulinemia in NMOSD patients with seropositive AQP4-IgG and the serum levels of interleukin (IL)-6 and IL-17A compared with the control group.<\/jats:p>\n                <jats:p>Serum levels of metabolic (Insulin, Fasting Blood Sugar (FBS), lipid profile) and inflammatory (IL-6 and IL-17) markers were assessed in 56 NMOSD patients and 100 controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Hyperinsulinemia was more prevalent in NMOSD patients independent of age, sex and body mass index (BMI) (48.2% vs. 26%, <jats:italic>p<\/jats:italic>\u2009=\u20090.005) compared to control group. After adjusting age, sex\u00a0and BMI, there was significant association between lower insulin sensitivity (IS) and NMOSD risk (95% CI: Beta\u2009=\u20090.73, 0.62 to 0.86, <jats:italic>p<\/jats:italic>\u2009=\u20090.0001).<\/jats:p>\n                <jats:p>Circulating levels of IL-6 and IL-17 were higher in NMOSD patients, and only IL-6 had an effect modifier for the association between lower insulin sensitivity and NMOSD risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data suggests that inflammatory pathogenesis of NMOSD leads to hyperinsulinemia and increases the risk of insulin resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02198-5","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T07:09:16Z","timestamp":1618902556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-6269","authenticated-orcid":false,"given":"Zhila","family":"Maghbooli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdorreza","family":"Naser Moghadasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Rezaeimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Omidifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarlan","family":"Varzandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"issue":"5","key":"2198_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107\u201314. https:\/\/doi.org\/10.1212\/WNL.53.5.1107.","journal-title":"Neurology"},{"key":"2198_CR2","doi-asserted-by":"publisher","unstructured":"Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, et al. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Front Neurol. 2020;11(501):1\u201313.\u00a0https:\/\/doi.org\/10.3389\/fneur.2020.00501.","DOI":"10.3389\/fneur.2020.00501"},{"key":"2198_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","volume":"18","author":"S Eskandarieh","year":"2017","unstructured":"Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA. Neuromyelitis optica spectrum disorders in Iran. Multiple Sclerosis Relat Disord. 2017;18:209\u201312. https:\/\/doi.org\/10.1016\/j.msard.2017.10.007.","journal-title":"Multiple Sclerosis Relat Disord"},{"issue":"14","key":"2198_CR4","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1177\/1352458514537699","volume":"20","author":"M Etemadifar","year":"2014","unstructured":"Etemadifar M, Dashti M, Vosoughi R, Abtahi SH, Ramagopalan SV, Nasr Z. An epidemiological study of neuromyelitis optica in Isfahan. Multiple sclerosis (Houndmills, Basingstoke, England). 2014;20(14):1920\u20132.","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"4","key":"2198_CR5","first-page":"204","volume":"14","author":"D Kashipazha","year":"2015","unstructured":"Kashipazha D, Mohammadianinejad SE, Majdinasab N, Azizi M, Jafari M. A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran. Irani J Neurol. 2015;14(4):204\u201310.","journal-title":"Irani J Neurol"},{"issue":"9","key":"2198_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805\u201315. https:\/\/doi.org\/10.1016\/S1474-4422(07)70216-8.","journal-title":"Lancet Neurol"},{"issue":"9451","key":"2198_CR7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106\u201312.","journal-title":"Lancet"},{"key":"2198_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.preteyeres.2013.03.001","volume":"36","author":"MH Levin","year":"2013","unstructured":"Levin MH, Bennett JL, Verkman AS. Optic neuritis in neuromyelitis optica. Prog Retin Eye Res. 2013;36:159\u201371. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.03.001.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"2198_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00281-018-0723-8","volume":"41","author":"SM Gold","year":"2019","unstructured":"Gold SM, Willing A, Leypoldt F, Paul F, Friese MA. Sex differences in autoimmune disorders of the central nervous system. Semin Immunopathol. 2019;41(2):177\u201388. https:\/\/doi.org\/10.1007\/s00281-018-0723-8.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"2198_CR10","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","volume":"2","author":"A Zekeridou","year":"2015","unstructured":"Zekeridou A, Lennon VA. Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e110. https:\/\/doi.org\/10.1212\/NXI.0000000000000110.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"2198_CR11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964\u20138. https:\/\/doi.org\/10.1001\/archneur.63.7.964.","journal-title":"Arch Neurol"},{"issue":"4","key":"2198_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","volume":"92","author":"BG Weinshenker","year":"2017","unstructured":"Weinshenker BG, Wingerchuk DM. Neuromyelitis Spectrum disorders. Mayo Clin Proc. 2017;92(4):663\u201379. https:\/\/doi.org\/10.1016\/j.mayocp.2016.12.014.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2198_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.21753","volume":"66","author":"S Ito","year":"2009","unstructured":"Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. \u201cCloud-like enhancement\u201d is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009;66(3):425\u20138. https:\/\/doi.org\/10.1002\/ana.21753.","journal-title":"Ann Neurol"},{"key":"2198_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.msard.2018.09.040","volume":"27","author":"X Wang","year":"2019","unstructured":"Wang X, Jiao W, Lin M, Lu C, Liu C, Wang Y, et al. Resolution of inflammation in neuromyelitis optica spectrum disorders. Multiple Sclerosis Relat Disord. 2019;27:34\u201341. https:\/\/doi.org\/10.1016\/j.msard.2018.09.040.","journal-title":"Multiple Sclerosis Relat Disord"},{"issue":"2","key":"2198_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/jir.2012.0040","volume":"33","author":"KC Wang","year":"2013","unstructured":"Wang KC, Lee C-L, Chen S-Y, Chen J-C, Yang C-W, Chen S-J, et al. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis. J Interf Cytokine Res. 2013;33(2):58\u201364. https:\/\/doi.org\/10.1089\/jir.2012.0040.","journal-title":"J Interf Cytokine Res"},{"issue":"1","key":"2198_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bpa.12097","volume":"24","author":"A Uzawa","year":"2014","unstructured":"Uzawa A, Masahiro M, Kuwabara S. Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications. Brain Pathol. 2014;24(1):67\u201373. https:\/\/doi.org\/10.1111\/bpa.12097.","journal-title":"Brain Pathol"},{"issue":"5091","key":"2198_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (New York, NY). 1993;259(5091):87\u201391.","journal-title":"Science (New York, NY)"},{"issue":"1","key":"2198_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1210\/en.2006-0692","volume":"148","author":"J Jager","year":"2007","unstructured":"Jager J, Gr\u00e9meaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology. 2007;148(1):241\u201351. https:\/\/doi.org\/10.1210\/en.2006-0692.","journal-title":"Endocrinology"},{"issue":"1","key":"2198_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","volume":"582","author":"C de Luca","year":"2008","unstructured":"de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;582(1):97\u2013105. https:\/\/doi.org\/10.1016\/j.febslet.2007.11.057.","journal-title":"FEBS Lett"},{"issue":"3","key":"2198_CR20","first-page":"465473","volume":"37","author":"S Casta\u00f1eda","year":"2019","unstructured":"Casta\u00f1eda S, Remuzgo-Mart\u00ednez S, L\u00f3pez-Mej\u00edas R, Genre F, Calvo-Al\u00e9n J, Llorente I, et al. Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis. Clin Exp Rheumatol. 2019;37(3):465473.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"2198_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1177\/0961203320935185","volume":"29","author":"C-Y Kuo","year":"2020","unstructured":"Kuo C-Y, Tsai T-Y, Huang Y-C. Insulin resistance and serum levels of adipokines in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus. 2020;29(9):1078\u201384. https:\/\/doi.org\/10.1177\/0961203320935185.","journal-title":"Lupus"},{"key":"2198_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnagi.2019.00236","volume":"11","author":"A Camins","year":"2019","unstructured":"Camins A, Lopez JF, Olloquequi J, Ettcheto M, Busquets O, Sanchez L\u00f3pez E, et al. The involvement of peripheral and brain insulin resistance in late onset Alzheimer\u2019s dementia. Front Aging Neurosci. 2019;11:236.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2198_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nut.2013.08.001","volume":"30","author":"SR Oliveira","year":"2014","unstructured":"Oliveira SR, Sim\u00e3o ANC, Kallaur AP, de Almeida ERD, Morimoto HK, Lopes J, et al. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition. 2014;30(3):268\u201373. https:\/\/doi.org\/10.1016\/j.nut.2013.08.001.","journal-title":"Nutrition"},{"key":"2198_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.msard.2018.08.014","volume":"25","author":"A Ruiz-Arg\u00fcelles","year":"2018","unstructured":"Ruiz-Arg\u00fcelles A, M\u00e9ndez-Huerta MA, Lozano CD, Ruiz-Arg\u00fcelles GJ. Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease. Multiple Sclerosis Relat Disord. 2018;25:316\u201321. https:\/\/doi.org\/10.1016\/j.msard.2018.08.014.","journal-title":"Multiple Sclerosis Relat Disord"},{"issue":"Suppl 2","key":"2198_CR25","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar4688","volume":"16 Suppl 2","author":"RH Straub","year":"2014","unstructured":"Straub RH. Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases. Arthritis Res Ther. 2014;16 Suppl 2(Suppl 2):S4.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"2198_CR26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s001250051451","volume":"42","author":"JM Fern\u00e1ndez-Real","year":"1999","unstructured":"Fern\u00e1ndez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype\/phenotype to thriftiness. Diabetologia. 1999;42(11):1367\u201374. https:\/\/doi.org\/10.1007\/s001250051451.","journal-title":"Diabetologia"},{"issue":"13","key":"2198_CR27","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1177\/0961203311411348","volume":"20","author":"MAB Lozovoy","year":"2011","unstructured":"Lozovoy MAB, Simao A, Hohmann M, Simao T, Barbosa D, Morimoto HK, et al. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome. Lupus. 2011;20(13):1356\u201364. https:\/\/doi.org\/10.1177\/0961203311411348.","journal-title":"Lupus"},{"issue":"10","key":"2198_CR28","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000216139.44259.74.","journal-title":"Neurology"},{"issue":"5","key":"2198_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","volume":"16","author":"B Balkau","year":"1999","unstructured":"Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of insulin resistance (EGIR). Diabetic Med. 1999;16(5):442\u20133. https:\/\/doi.org\/10.1046\/j.1464-5491.1999.00059.x.","journal-title":"Diabetic Med"},{"issue":"6","key":"2198_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/01.HYP.20.6.797","volume":"20","author":"L Lissner","year":"1992","unstructured":"Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension (Dallas, Tex : 1979). 1992;20(6):797\u2013801.","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"7","key":"2198_CR31","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402\u201310. https:\/\/doi.org\/10.1210\/jcem.85.7.6661.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2198_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11011-015-9665-1","volume":"30","author":"A Penesova","year":"2015","unstructured":"Penesova A, Vlcek M, Imrich R, Vernerova L, Marko A, Meskova M, et al. Hyperinsulinemia in newly diagnosed patients with multiple sclerosis. Metab Brain Dis. 2015;30(4):895\u2013901. https:\/\/doi.org\/10.1007\/s11011-015-9665-1.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"2198_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41983-020-0155-y","volume":"56","author":"RH Soliman","year":"2020","unstructured":"Soliman RH, Farhan HM, Hegazy M, Oraby MI, Kamel SH, Hassan A. Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis. Egypt J Neurol Psychiatry Neurosurg. 2020;56(1):18.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"2198_CR34","doi-asserted-by":"publisher","first-page":"5314541","DOI":"10.1155\/2016\/5314541","volume":"2016","author":"GR Dos Passos","year":"2016","unstructured":"Dos Passos GR, Sato DK, Becker J, Fujihara K. Th17 cells pathways in multiple sclerosis and Neuromyelitis Optica Spectrum disorders: pathophysiological and therapeutic implications. Mediat Inflamm. 2016;2016:5314541.","journal-title":"Mediat Inflamm"},{"key":"2198_CR35","doi-asserted-by":"publisher","unstructured":"Thoman ME, McKarns SC. Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery. Metabolites. 2020;10(9):374.\u00a0 https:\/\/doi.org\/10.3390\/metabo10090374. PMID: 32961928; PMCID: PMC7570337.","DOI":"10.3390\/metabo10090374"},{"issue":"1\u20132","key":"2198_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2017.12.025","volume":"172","author":"YS Lee","year":"2018","unstructured":"Lee YS, Wollam J, Olefsky JM. An integrated view of Immunometabolism. Cell. 2018;172(1\u20132):22\u201340. https:\/\/doi.org\/10.1016\/j.cell.2017.12.025.","journal-title":"Cell"},{"issue":"8","key":"2198_CR37","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1073\/pnas.051042298","volume":"98","author":"ON Ozes","year":"2001","unstructured":"Ozes ON, Akca H, Mayo LD, Gustin JA, Maehama T, Dixon JE, et al. A phosphatidylinositol 3-kinase\/Akt\/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A. 2001;98(8):4640\u20135. https:\/\/doi.org\/10.1073\/pnas.051042298.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"2198_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11010-019-03561-4","volume":"459","author":"L Tao","year":"2019","unstructured":"Tao L, Liu H, Gong Y. Role and mechanism of the Th17\/Treg cell balance in the development and progression of insulin resistance. Mol Cell Biochem. 2019;459(1\u20132):183\u20138. https:\/\/doi.org\/10.1007\/s11010-019-03561-4.","journal-title":"Mol Cell Biochem"},{"key":"2198_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0083-6729(08)00621-3","volume":"80","author":"JH Kim","year":"2009","unstructured":"Kim JH, Bachmann RA, Chen J. Interleukin-6 and insulin resistance. Vitam Horm. 2009;80:613\u201333. https:\/\/doi.org\/10.1016\/S0083-6729(08)00621-3.","journal-title":"Vitam Horm"},{"issue":"1","key":"2198_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bpa.12097","volume":"24","author":"A Uzawa","year":"2014","unstructured":"Uzawa A, Mori M, Kuwabara S. Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications. Brain Pathol (Zurich, Switzerland). 2014;24(1):67\u201373.","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"key":"2198_CR41","doi-asserted-by":"publisher","first-page":"104315","DOI":"10.1016\/j.neuint.2018.10.012","volume":"130","author":"M Araki","year":"2019","unstructured":"Araki M. Blockade of IL-6 signaling in neuromyelitis optica. Neurochem Int. 2019;130:104315. https:\/\/doi.org\/10.1016\/j.neuint.2018.10.012.","journal-title":"Neurochem Int"},{"issue":"5","key":"2198_CR42","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000841","volume":"7","author":"K Fujihara","year":"2020","unstructured":"Fujihara K, Bennett JL, de Seze J, Haramura M, Kleiter I, Weinshenker BG, et al. Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e841. https:\/\/doi.org\/10.1212\/NXI.0000000000000841.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2198_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2019.01.015","volume":"330","author":"C Monteiro","year":"2019","unstructured":"Monteiro C, Fernandes G, Kasahara TM, Barros PO, Dias AS, Ara\u00fajo ACR, et al. The expansion of circulating IL-6 and IL-17-secreting follicular helper T cells is associated with neurological disabilities in neuromyelitis optica spectrum disorders. J Neuroimmunol. 2019;330:12\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.015.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2198_CR44","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","volume":"171","author":"G Cassese","year":"2003","unstructured":"Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M, et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol. 2003;171(4):1684\u201390. https:\/\/doi.org\/10.4049\/jimmunol.171.4.1684.","journal-title":"J Immunol"},{"issue":"15","key":"2198_CR45","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","volume":"82","author":"M Araki","year":"2014","unstructured":"Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M, et al. Efficacy of the anti\u2013IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology. 2014;82(15):1302\u20136. https:\/\/doi.org\/10.1212\/WNL.0000000000000317.","journal-title":"Neurology"},{"issue":"1","key":"2198_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/00207450903428970","volume":"120","author":"S \u0130\u0130\u00e7\u00f6z","year":"2010","unstructured":"\u0130\u0130\u00e7\u00f6z S, T\u00fcz\u00fcn E, K\u00fcrt\u00fcnc\u00fc M, Durmu\u015f\u015f H, Mutlu M, Eraksoy M, et al. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int J Neurosci. 2010;120(1):71\u20135. https:\/\/doi.org\/10.3109\/00207450903428970.","journal-title":"Int J Neurosci"},{"issue":"12","key":"2198_CR47","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1212\/01.WNL.0000148481.80152.BF","volume":"63","author":"J Correale","year":"2004","unstructured":"Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology. 2004;63(12):2363\u201370. https:\/\/doi.org\/10.1212\/01.WNL.0000148481.80152.BF.","journal-title":"Neurology"},{"issue":"1","key":"2198_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC, Behrmann I, Haan S, Hermanns HM, M\u00fcller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374(1):1\u201320. https:\/\/doi.org\/10.1042\/bj20030407.","journal-title":"Biochem J"},{"key":"2198_CR49","first-page":"508409","volume":"2015","author":"L Chen","year":"2015","unstructured":"Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015;2015:508409.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"2198_CR50","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.2569","volume":"14","author":"DA Bermejo","year":"2013","unstructured":"Bermejo DA, Jackson SW, Gorosito-Serran M, Acosta-Rodriguez EV, Amezcua-Vesely MC, Sather BD, et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR\u03b3t and Ahr that leads to IL-17 production by activated B cells. Nat Immunol. 2013;14(5):514\u201322. https:\/\/doi.org\/10.1038\/ni.2569.","journal-title":"Nat Immunol"},{"issue":"6068","key":"2198_CR51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1126\/science.1215173","volume":"335","author":"PJ Rauch","year":"2012","unstructured":"Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I, et al. Innate response activator B cells protect against microbial sepsis. Science (New York, NY). 2012;335(6068):597\u2013601.","journal-title":"Science (New York, NY)"},{"issue":"11","key":"2198_CR52","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.4049\/jimmunol.1001269","volume":"185","author":"LA Z\u00fa\u00f1iga","year":"2010","unstructured":"Z\u00fa\u00f1iga LA, Shen W-J, Joyce-Shaikh B, Pyatnova EA, Richards AG, Thom C, et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010;185(11):6947\u201359. https:\/\/doi.org\/10.4049\/jimmunol.1001269.","journal-title":"J Immunol"},{"key":"2198_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.imlet.2017.02.004","volume":"184","author":"SH Lee","year":"2017","unstructured":"Lee SH, Jhun J, Byun JK, Kim EK, Jung K, Lee JE, et al. IL-17 axis accelerates the inflammatory progression of obese in mice via TBK1 and IKBKE pathway. Immunol Lett. 2017;184:67\u201375. https:\/\/doi.org\/10.1016\/j.imlet.2017.02.004.","journal-title":"Immunol Lett"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02198-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02198-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02198-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T07:12:36Z","timestamp":1618902756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02198-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02198-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in the Ethical Committee of the National Institute for Medical Research Development of Iran, Ministry of Health and Medical Education (IR.NIMAD.REC.1398.159).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}